Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,406,145
-$272,069 QoQ
Shares Held
99,923
+4.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
#878
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Shoker Investment Counsel, Inc. holds $20,628,640 across 8 Drug Manufacturers - General names. PFE ranks #5 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
21,930 | $5,518,465 | |
| 2 | JNJ |
Johnson & Johnson
|
18,845 | $4,786,064 | |
| 3 | MRK |
Merck & Co., Inc.
|
29,948 | $3,848,318 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
20,774 | $2,624,587 | |
| 5 | PFE |
Pfizer Inc
This page
|
99,923 | $2,406,145 | |
| 6 | LLY |
ELI LILLY & Co
|
668 | $801,219 | |
| 7 | NVS |
Novartis AG
|
2,335 | $365,941 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,823 | $277,901 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,406,145 | 99,923 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,678,214 | 95,378 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,512,310 | 100,896 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $2,891,419 | 113,478 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $2,753,397 | 113,589 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,101,793 | 122,407 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,327,976 | 125,442 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,592,003 | 124,119 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $3,865,045 | 138,136 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,292,650 | 46,582 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $1,528,892 | 53,105 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,713,661 | 51,663 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,895,365 | 51,673 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $2,111,481 | 51,752 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $2,660,739 | 51,927 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,281,777 | 52,143 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,619,088 | 49,954 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,468,238 | 47,677 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $2,820,168 | 47,759 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $2,087,017 | 48,524 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $1,900,787 | 48,539 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,724,077 | 47,587 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,778,548 | 48,317 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,675,610 | 45,657 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,476,112 | 45,141 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $1,456,166 | 44,613 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||